Developer docs
API playgroundTry for free, no card

Search company profiles

Seers Technology

Full company profile

uuid0004wd4

Namestring
Seers Technology
Legal namestring
SEERS Technology Co., Ltd.
Websiteurl
seers.co.kr
Company typeenum
Public
Founded yearint
2009
Descriptiontext

Seers Technology (rebranding to SEERS) is a South Korea-based digital healthcare company, founded in 2009 and listed on KOSDAQ under ticker 458870, that develops and commercializes wearable biosensors and AI-powered patient monitoring platforms for hospitals and outpatient cardiology use. Its product portfolio is anchored by two platforms: mobiCARE™, a subscription-based wearable ECG analysis service using a patch-type biosensor capable of up to 9 days of continuous monitoring and an AI algorithm that detects 14+ types of arrhythmias from deep-learning analysis of ECG waveforms validated on data from over 80,000 patients; and thynC™, a real-time inpatient monitoring system integrating patch-type ECG, temperature, and pulse oximetry sensors with a gateway, central nursing dashboard, mobile monitoring app, and an AI-driven Early Warning Score that fuses heart rate, blood pressure, respiration, and temperature to flag patient deterioration. Seers also sells standalone wearable biosensors (Holter ECG, IR temperature patch, pulse oximeter) and medical adhesive materials through an OEM/ODM line, all manufactured under GMP with ISO 13485, MDSAP, MFDS, FDA 510(k), and CE certifications.

The company generates revenue through a mix of subscription-based software/services (mobiCARE ECG analysis, thynC monitoring subscriptions), hardware sales of biosensor devices, and licensing/integration of third-party devices such as Sky Labs' CART ON ring into thynC. Domestic distribution runs primarily through enterprise direct sales plus an exclusive channel partnership with Daewoong Pharmaceutical, which targets scaling thynC from 15,000 to 100,000 Korean hospital beds; international expansion is led through a strategic partnership with PureHealth in the UAE as the first overseas foothold, with Middle East and United States entry planned. In FY2025 Seers reported 48.17 billion KRW (~$36M USD) in revenue, up 495% year-on-year, with its first full-year operating profit of 16.33 billion KRW, making it Korea's first publicly listed medical AI company to achieve annual profitability. The thynC platform is currently installed across 12,000+ beds at 128 domestic hospitals (and adopted by a broader set of 400–700+ hospitals across product lines), with new functions added via partnerships with SkyLab, iKooB, and Puzzle AI.

Short descriptiontext

Seers Technology (rebranding as SEERS) is a KOSDAQ-listed South Korean digital healthcare company that sells AI-powered wearable biosensors and inpatient monitoring platforms (mobiCARE ECG analysis and thynC hospital monitoring) to hospitals and outpatient cardiology providers, primarily in Korea with expanding presence in the UAE.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersSeongnam, South Korea
HQ citystring
Seongnam
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, wearable ECG analysis, AI patient monitoring, digital healthcare platform, medical biosensors
Industry4 codes
1Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
CodeHLACAPAIPrimaryYes
2Connected Medical Devices & Wearables (Sensors, Patches, Implantables)
CodeHLACAPABPrimaryNo
3Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
CodeHLAHACABPrimaryNo
4Wearables & Consumer IoT Integration Platforms (BYOD)
CodeHLACAFAFPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Patient Monitoring
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1thynC Platform Revenue
TypeSubscription Recurring
Description

Revenue from the thynC inpatient monitoring platform including wearable biosensors, gateway devices, dashboards, and monitoring software. Installed in over 12,000 beds across 128 domestic hospitals.

koreabiomed.com
2mobiCARE ECG Analysis Service
TypeSubscription Recurring
Description

First subscription-based ECG analysis service in Korea. Provides wearable ECG monitoring with AI analysis and specialist-reviewed reports for outpatients and health checkups.

seers.co.kr
3Wearable Biosensor Hardware
TypeHardware Sales
Description

Sales of wearable medical devices including ECG holters, thermometers, pulse oximeters, and related sensors.

seers.co.kr
4Technology Integration (thynC)
TypeLicensing Royalties
Description

Integration of third-party devices like Sky Labs' CART ON blood pressure ring into the thynC platform for hospital inpatient monitoring.

prnewswire.co.uk
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details3 tiers
1mobiCARE Premium - Full ECG analysis with specialist review
ModelSubscriptionBilling cadenceMonthly
Notes

Premium tier includes analysis program and report reviewed by arrhythmia specialists

seers.co.kr
2mobiCARE Standard - AI analysis only
ModelSubscriptionBilling cadenceMonthly
Notes

Standard tier includes analysis program without specialist review

seers.co.kr
3Health Checkup ECG Service - Variable duration options
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Options include same-day (5H), Checkup 1 (24H), Checkup 2 (48H), Checkup 3 (72H), Checkup 7 (168H) with varying service levels including refresh service

seers.co.kr
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1mobiCARE™
Description

First subscription-based ECG analysis service in Korea. Provides wearable Holter electrocardiogram for arrhythmia detection with up to 9-day continuous monitoring and AI-based analysis algorithms detecting 14+ types of arrhythmias.

seers.co.kr
+1 more record
Core offering1 text field

Seers Technology develops and sells AI-powered wearable biosensors and patient monitoring platforms. Its two flagship solutions are thynC, a real-time inpatient monitoring platform that integrates wearable sensors, gateways, central and mobile dashboards for continuous vital sign collection and AI-driven early warning alerts in hospitals, and mobiCARE, Korea's first subscription-based ECG analysis service using a patch-type wearable holter with AI arrhythmia detection for outpatients and health checkup centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 12,000+ cumulative installed beds across 128 hospitals
+4 more records
Product overview1 text field

Seers Technology (rebranding as SEERS) is a digital healthcare company offering an integrated platform of remote patient monitoring solutions. Its product portfolio consists of two core platforms: mobiCARE™ (a subscription-based wearable ECG analysis solution for outpatients) and thynC™ (a real-time inpatient monitoring solution), both supported by a range of wearable biosensor devices (Electrocardiographic Holter analyser, Thermometer, Pulse Oximeter), patient monitoring software (Monitoring Dashboard, Hospital Ward Managing Software, Mobile Monitoring Software), and Medical AI features (ECG Analysis Algorithm, Temperature Monitoring AI, Early Warning Score, Location Tracking, Fall Detection, Activity Measurement). The company also offers Medical Adhesive Materials for its wearable sensors. All products are produced within GMP-certified manufacturing infrastructure and leverage proprietary AI algorithms validated through clinical studies.

Product and service6 records
1mobiCARE™
CategoryRemote ECG Monitoring Service
Description

Korea's first subscription-based ECG analysis solution combining a patch-type wearable biosensor (up to 9-day continuous monitoring), a deep learning-powered analysis program, and arrhythmia specialist-reviewed reports to detect 14+ types of arrhythmias for outpatients and health checkup centers.

2thynC™
CategoryInpatient Patient Monitoring Platform
Description

Real-time inpatient monitoring solution that integrates wearable biosensors, an IoT gateway, a central dashboard, and a mobile dashboard to continuously measure, collect, transmit, store, and analyze patient biometric signals, with AI-powered Early Warning Score alerts to reduce gaps in patient management in hospitals.

3Wearable Holter ECG (Electrocardiographic Holter analyser)
CategoryWearable Medical Device
Description

A patch-type wearable ECG device optimized for arrhythmia detection, capable of continuous monitoring for up to 9 days without battery replacement, designed for patients, doctors, and analysis experts to increase diagnostic accuracy.

4Wearable Patch Thermometer
CategoryWearable Medical Device
Description

A patch-type thermometer using an infrared sensor for continuous body temperature monitoring, made with skin-friendly silicone material to reduce infection risk and skin irritation.

5Wearable Pulse Oximeter
CategoryWearable Medical Device
Description

A wearable pulse oximeter using a reusable sensor and disposable universal probe that measures oxygen saturation, heart rate, respiration rate, and perfusion index without blood collection, with medical device certification and clinically proven stability and efficacy.

6Medical Adhesive Materials
CategoryMedical Consumables
Description

Medical-grade adhesive solutions including silicone gel, hydrocolloid, conductive hydrogel, and adhesive hydrogel for long-term skin-friendly wear of patch-type wearable biosensors, along with medical patch products and OEM/ODM manufacturing services.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-23
Description

Daewoong Pharmaceutical serves as Korea's exclusive distributor for Seers Technology's thynC patient monitoring platform. Daewoong plans to expand the thynC system to 100,000 hospital beds by end of 2026 (up from 15,000 beds at 162 hospitals). Daewoong also added three new functions from SkyLab, iKooB, and Puzzle AI to the platform. Daewoong has exclusive domestic sales rights and plans nationwide hospital distribution.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-02-10
Description

Sky Labs' CART ON ring-type blood pressure monitor integrates with Seers' thynC inpatient monitoring platform. Data from the wearable ring device is automatically transmitted to nursing station dashboards and hospital EMR systems via thynC. This expands thynC's monitoring capabilities to include cuffless blood pressure monitoring for hospital inpatients.

Strategic tierStrategicTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-01
Description

Partnership with PureHealth for UAE market expansion as a strategic foothold for international growth. This represents Seers' first major overseas market entry.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

GE HealthCare provides multi-parameter patient monitoring systems and AI-enabled clinical tools across hospital environments, competing with Seers' thynC inpatient monitoring platform in larger Korean tertiary hospitals.

TypeBroad incumbent
Description

Hillrom (acquired by Baxter) supplies hospital patient monitoring and connected care solutions including wearable sensors and nurse communication systems, competing in the inpatient monitoring category Seers targets with thynC.

TypeEmerging player
Description

Biobeat offers wearable continuous vital sign monitoring patches with AI analytics for inpatient and remote patient monitoring, comparable to Seers' thynC platform in the connected RPM space.

TypeRegional player
Description

VUNO is a Korean medical AI company listed on KOSDAQ that develops AI-based clinical decision support tools, a regional peer in the Korean medical AI ecosystem targeting similar hospital customers.

TypeDirect peer
Description

iRhythm's Zio patch is a direct competitor to Seers' mobiCARE wearable Holter ECG, offering multi-day continuous ECG monitoring with AI-based arrhythmia detection for outpatient and ambulatory use.

TypeDirect peer
Description

AliveCor's KardiaMobile personal ECG devices and AI-based arrhythmia detection service offer a consumer-grade subscription alternative to Seers' mobiCARE outpatient ECG analysis service.

TypeDirect peer
Description

Masimo's wearable patient monitoring sensors (like Radius PPG and SET pulse oximetry) and connected care platform compete with Seers' pulse oximetry, temperature, and remote vital signs monitoring offerings.

TypeBroad incumbent
Description

Philips offers broad inpatient and ambulatory patient monitoring solutions including wearable biosensors, central stations, and AI analytics, overlapping directly with Seers' thynC platform across Korean and Asian hospital markets.

TypeDirect peer
Description

Preventice's BodyGuardian remote cardiac monitoring system uses wearable ECG patches with AI arrhythmia detection for ambulatory monitoring, directly comparable to Seers' mobiCARE subscription service.

TypeEmerging player
Description

VivaLNK provides connected wearable biosensor patches and RPM platforms used by hospitals and clinical trials, comparable to Seers' thynC integration with multi-vendor wearable devices.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Seers Technology

Remote Patient Monitoringseers.co.kr

Seers Technology (rebranding as SEERS) is a KOSDAQ-listed South Korean digital healthcare company that sells AI-powered wearable biosensors and inpatient monitoring platforms (mobiCARE ECG analysis and thynC hospital monitoring) to hospitals and outpatient cardiology providers, primarily in Korea with expanding presence in the UAE.

What Seers Technology does

Seers Technology (rebranding to SEERS) is a South Korea-based digital healthcare company, founded in 2009 and listed on KOSDAQ under ticker 458870, that develops and commercializes wearable biosensors and AI-powered patient monitoring platforms for hospitals and outpatient cardiology use. Its product portfolio is anchored by two platforms: mobiCARE™, a subscription-based wearable ECG analysis service using a patch-type biosensor capable of up to 9 days of continuous monitoring and an AI algorithm that detects 14+ types of arrhythmias from deep-learning analysis of ECG waveforms validated on data from over 80,000 patients; and thynC™, a real-time inpatient monitoring system integrating patch-type ECG, temperature, and pulse oximetry sensors with a gateway, central nursing dashboard, mobile monitoring app, and an AI-driven Early Warning Score that fuses heart rate, blood pressure, respiration, and temperature to flag patient deterioration. Seers also sells standalone wearable biosensors (Holter ECG, IR temperature patch, pulse oximeter) and medical adhesive materials through an OEM/ODM line, all manufactured under GMP with ISO 13485, MDSAP, MFDS, FDA 510(k), and CE certifications.

The company generates revenue through a mix of subscription-based software/services (mobiCARE ECG analysis, thynC monitoring subscriptions), hardware sales of biosensor devices, and licensing/integration of third-party devices such as Sky Labs' CART ON ring into thynC. Domestic distribution runs primarily through enterprise direct sales plus an exclusive channel partnership with Daewoong Pharmaceutical, which targets scaling thynC from 15,000 to 100,000 Korean hospital beds; international expansion is led through a strategic partnership with PureHealth in the UAE as the first overseas foothold, with Middle East and United States entry planned. In FY2025 Seers reported 48.17 billion KRW (~$36M USD) in revenue, up 495% year-on-year, with its first full-year operating profit of 16.33 billion KRW, making it Korea's first publicly listed medical AI company to achieve annual profitability. The thynC platform is currently installed across 12,000+ beds at 128 domestic hospitals (and adopted by a broader set of 400–700+ hospitals across product lines), with new functions added via partnerships with SkyLab, iKooB, and Puzzle AI.

Seers Technology firmographics

Firmographics
Name
Seers Technology
Legal name
SEERS Technology Co., Ltd.
Website
https://seers.co.kr
Company type
Public
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
Seers Technology (rebranding as SEERS) is a KOSDAQ-listed South Korean digital healthcare company that sells AI-powered wearable biosensors and inpatient monitoring platforms (mobiCARE ECG analysis and thynC hospital monitoring) to hospitals and outpatient cardiology providers, primarily in Korea with expanding presence in the UAE.
Ownership category
akta.pro rank

Seers Technology industry classification

Industry
Product category
Remote Patient Monitoring
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
akta.pro secondary industries
Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB), Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF)

Keywords

  • Remote patient monitoring
  • Wearable ECG analysis
  • AI patient monitoring
  • Digital healthcare platform
  • Medical biosensors

Where Seers Technology is headquartered

Location

Headquarters

HQ city
Seongnam
HQ country
South Korea
HQ region
Asia

Offices3 records

Markets served

Seers Technology business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. thynC Platform Revenue: Revenue from the thynC inpatient monitoring platform including wearable biosensors, gateway devices, dashboards, and monitoring software. Installed in over 12,000 beds across 128 domestic hospitals.
  2. mobiCARE ECG Analysis Service: First subscription-based ECG analysis service in Korea. Provides wearable ECG monitoring with AI analysis and specialist-reviewed reports for outpatients and health checkups.
  3. Wearable Biosensor Hardware: Sales of wearable medical devices including ECG holters, thermometers, pulse oximeters, and related sensors.
  4. Technology Integration (thynC): Integration of third-party devices like Sky Labs' CART ON blood pressure ring into the thynC platform for hospital inpatient monitoring.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlymobiCARE Premium - Full ECG analysis with specialist review
SubscriptionMonthlymobiCARE Standard - AI analysis only
SubscriptionPay-as-you-goHealth Checkup ECG Service - Variable duration options

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Seers Technology product offering

Product offering

Core offering

Seers Technology develops and sells AI-powered wearable biosensors and patient monitoring platforms. Its two flagship solutions are thynC, a real-time inpatient monitoring platform that integrates wearable sensors, gateways, central and mobile dashboards for continuous vital sign collection and AI-driven early warning alerts in hospitals, and mobiCARE, Korea's first subscription-based ECG analysis service using a patch-type wearable holter with AI arrhythmia detection for outpatients and health checkup centers.

Product overview

Seers Technology (rebranding as SEERS) is a digital healthcare company offering an integrated platform of remote patient monitoring solutions. Its product portfolio consists of two core platforms: mobiCARE™ (a subscription-based wearable ECG analysis solution for outpatients) and thynC™ (a real-time inpatient monitoring solution), both supported by a range of wearable biosensor devices (Electrocardiographic Holter analyser, Thermometer, Pulse Oximeter), patient monitoring software (Monitoring Dashboard, Hospital Ward Managing Software, Mobile Monitoring Software), and Medical AI features (ECG Analysis Algorithm, Temperature Monitoring AI, Early Warning Score, Location Tracking, Fall Detection, Activity Measurement). The company also offers Medical Adhesive Materials for its wearable sensors. All products are produced within GMP-certified manufacturing infrastructure and leverage proprietary AI algorithms validated through clinical studies.

Differentiator

Problem solved

Functional benefit

Brands

  • mobiCARE™: First subscription-based ECG analysis service in Korea. Provides wearable Holter electrocardiogram for arrhythmia detection with up to 9-day continuous monitoring and AI-based analysis algorithms detecting 14+ types of arrhythmias.
  • thynC™

Products and services

  • mobiCARE™ Korea's first subscription-based ECG analysis solution combining a patch-type wearable biosensor (up to 9-day continuous monitoring), a deep learning-powered analysis program, and arrhythmia specialist-reviewed reports to detect 14+ types of arrhythmias for outpatients and health checkup centers.
  • thynC™ Real-time inpatient monitoring solution that integrates wearable biosensors, an IoT gateway, a central dashboard, and a mobile dashboard to continuously measure, collect, transmit, store, and analyze patient biometric signals, with AI-powered Early Warning Score alerts to reduce gaps in patient management in hospitals.
  • Wearable Holter ECG (Electrocardiographic Holter analyser) A patch-type wearable ECG device optimized for arrhythmia detection, capable of continuous monitoring for up to 9 days without battery replacement, designed for patients, doctors, and analysis experts to increase diagnostic accuracy.
  • Wearable Patch Thermometer A patch-type thermometer using an infrared sensor for continuous body temperature monitoring, made with skin-friendly silicone material to reduce infection risk and skin irritation.
  • Wearable Pulse Oximeter A wearable pulse oximeter using a reusable sensor and disposable universal probe that measures oxygen saturation, heart rate, respiration rate, and perfusion index without blood collection, with medical device certification and clinically proven stability and efficacy.
  • Medical Adhesive Materials Medical-grade adhesive solutions including silicone gel, hydrocolloid, conductive hydrogel, and adhesive hydrogel for long-term skin-friendly wear of patch-type wearable biosensors, along with medical patch products and OEM/ODM manufacturing services.

Quantifiable outcome

  • 12,000+ cumulative installed beds across 128 hospitals
  • +4 more outcomes

Companies that use Seers Technology

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Seers Technology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Seers Technology partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and strategic.

  • Daewoong PharmaceuticalcoreChannel Partner/ Reseller/ Distributor · 23 February 2026Daewoong Pharmaceutical serves as Korea's exclusive distributor for Seers Technology's thynC patient monitoring platform. Daewoong plans to expand the thynC system to 100,000 hospital beds by end of 2026 (up from 15,000 beds at 162 hospitals). Daewoong also added three new functions from SkyLab, iKooB, and Puzzle AI to the platform. Daewoong has exclusive domestic sales rights and plans nationwide hospital distribution.
  • Sky LabscoreTechnology or Integration · 10 February 2026Sky Labs' CART ON ring-type blood pressure monitor integrates with Seers' thynC inpatient monitoring platform. Data from the wearable ring device is automatically transmitted to nursing station dashboards and hospital EMR systems via thynC. This expands thynC's monitoring capabilities to include cuffless blood pressure monitoring for hospital inpatients.
  • PureHealthstrategicChannel Partner/ Reseller/ Distributor · 1 January 2026Partnership with PureHealth for UAE market expansion as a strategic foothold for international growth. This represents Seers' first major overseas market entry.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Seers Technology competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: GE HealthCare provides multi-parameter patient monitoring systems and AI-enabled clinical tools across hospital environments, competing with Seers' thynC inpatient monitoring platform in larger Korean tertiary hospitals.
  • Hillrom (Baxter): Hillrom (acquired by Baxter) supplies hospital patient monitoring and connected care solutions including wearable sensors and nurse communication systems, competing in the inpatient monitoring category Seers targets with thynC.
  • Philips (Patient Monitoring): Philips offers broad inpatient and ambulatory patient monitoring solutions including wearable biosensors, central stations, and AI analytics, overlapping directly with Seers' thynC platform across Korean and Asian hospital markets.

Emerging players

  • Biobeat: Biobeat offers wearable continuous vital sign monitoring patches with AI analytics for inpatient and remote patient monitoring, comparable to Seers' thynC platform in the connected RPM space.
  • VivaLNK: VivaLNK provides connected wearable biosensor patches and RPM platforms used by hospitals and clinical trials, comparable to Seers' thynC integration with multi-vendor wearable devices.

Regional players

  • VUNO: VUNO is a Korean medical AI company listed on KOSDAQ that develops AI-based clinical decision support tools, a regional peer in the Korean medical AI ecosystem targeting similar hospital customers.

Direct peers

  • iRhythm Technologies: iRhythm's Zio patch is a direct competitor to Seers' mobiCARE wearable Holter ECG, offering multi-day continuous ECG monitoring with AI-based arrhythmia detection for outpatient and ambulatory use.
  • AliveCor: AliveCor's KardiaMobile personal ECG devices and AI-based arrhythmia detection service offer a consumer-grade subscription alternative to Seers' mobiCARE outpatient ECG analysis service.
  • Masimo: Masimo's wearable patient monitoring sensors (like Radius PPG and SET pulse oximetry) and connected care platform compete with Seers' pulse oximetry, temperature, and remote vital signs monitoring offerings.
  • Preventice Solutions (Boston Scientific): Preventice's BodyGuardian remote cardiac monitoring system uses wearable ECG patches with AI arrhythmia detection for ambulatory monitoring, directly comparable to Seers' mobiCARE subscription service.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Seers Technology social profiles

Digital presence

Seers Technology compliance and trust

Trust signal

Compliance9 records

Seers Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Seers Technology leadership team

Management profile

Number of profiles

Profiles6 records

Seers Technology funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Seers Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seers Technology

What does Seers Technology do?

Seers Technology develops and sells AI-powered wearable biosensors and patient monitoring platforms. Its two flagship solutions are thynC, a real-time inpatient monitoring platform that integrates wearable sensors, gateways, central and mobile dashboards for continuous vital sign collection and AI-driven early warning alerts in hospitals, and mobiCARE, Korea's first subscription-based ECG analysis service using a patch-type wearable holter with AI arrhythmia detection for outpatients and health checkup centers.

Is Seers Technology a public or private company?

Seers Technology is a public company. It is classified as public and is currently operating.

When was Seers Technology founded?

Seers Technology was founded in 2009. It employs 51 to 100 people.

Where is Seers Technology based?

Seers Technology is headquartered in Seongnam, South Korea, in the Asia region.

How does Seers Technology make money?

Four revenue lines are on record. thynC Platform Revenue is the primary driver. The others are mobiCARE ECG Analysis Service, wearable Biosensor Hardware and technology Integration (thynC).

Who are Seers Technology's main competitors?

Broad incumbents on record are GE HealthCare, Hillrom (Baxter) and Philips (Patient Monitoring). Emerging players are Biobeat and VivaLNK. VUNO is listed as a regional player. Direct peers are iRhythm Technologies, AliveCor, Masimo and Preventice Solutions (Boston Scientific).

Does Seers Technology have an API?

No public API is recorded for Seers Technology.

What industry is Seers Technology in?

Seers Technology's product category is Remote Patient Monitoring. Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLACAPAB, Connected Medical Devices & Wearables (Sensors, Patches, Implantables). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Simply Wall StAsian Growth Stocks With Strong Insider OwnershipA list of Asian growth stocks with high insider ownership is presented, including Zhejiang Taotao Vehicles, Suzhou Dongshan Precision Manufacturing, and SEERS, with insider ownership ranging from 11.2% to 33.8%. Earnings growth forecasts vary, with Great Microwave Technology projected at 95.2% and Shanghai Biren Technology at 47.1%.Simply Wall StAsian Growth Leaders With High Insider OwnershipA Simply Wall St article profiles Asian growth companies with high insider ownership, including Zhejiang Taotao Vehicles, Suzhou Dongshan Precision Manufacturing, and SEERS. It reports insider ownership percentages and annual earnings growth forecasts, such as 31.3% for Taotao and 72% for Dongshan. The piece also highlights Smoore International Holdings with a 39.6% insider stake and 28.4% earnings growth forecast.Simply Wall StAsian Insider Picks For High Growth In August 2026Simply Wall St published a list of Asian stocks with high insider ownership, citing Suzhou Dongshan Precision Manufacturing (33.5%), SEERS (33.8%) and Ningbo Sanxing Medical Electric (24.9%) among the top 10. The article also profiles SENASIC Electronics, Guangzhou Ruoyuchen Technology and Japan Elevator Service Holdings, projecting annual earnings growth of 32.4%, 34.71% and 16.15% respectively.ChosunbizSeers beats 2023 profit in H1 as thynC drives Korea hospital growthSeers reported first-half revenue of 60.9 billion won and an operating profit of 26.8 billion won, significantly surpassing its full-year 2023 figures driven by growth in its thynC inpatient monitoring platform. The company is now expanding its domestic operations and accelerating overseas expansion into the United States and the UAE with its mobiCARE solution.DaumSeahorse, think about restructuring the operating system... Establishing a new hospital CX organization to strengthen competitiveness.Wearable AI diagnostic monitoring company Seers has reorganized its Think Connected Hub into a business unit system to enhance platform competitiveness. The restructuring established a dedicated customer experience (CX) organization and separated infrastructure functions to improve operational efficiency and service quality across its 220 partner medical institutions. The company aims to leverage accumulated field data as a barrier to entry as it expands beyond its current coverage of 20,000 hospital beds.MobiHealthNewsLatest Middle East partnerships expanding Korean health tech and more briefsKorean health tech companies ROKIT Healthcare and Seers signed partnerships with Middle East healthcare firms to expand their AI-enabled health monitoring technologies. The University of Hong Kong developed a saliva-based AI detection device for rapid cancer risk assessment, and South Korea's National Cancer Center created AI for near real-time gastric cancer detection during surgery.KBRSeers Technology to rebrand as SEERS, signaling global digital healthcare pushSeers Technology, Korea's first publicly listed medical AI company to achieve annual profit, announced it will rebrand as SEERS at its 17th annual general meeting on Friday, marking its first brand renewal since its founding in 2009. The rebranding reflects a strategic shift from a wearable AI diagnostic company to a patient-centered, next-generation digital healthcare platform, with a new slogan "Connected Intelligence, Continuous Care" and plans to expand into overseas markets including the Middle East and the United States.ChosunbizSangsangin hikes Seers Technology target as thynC drives Korea sales surgeSangsangin Investment & Securities raised its target price for Seers Technology to 260,000 won, citing strong sales growth of its inpatient monitoring platform thynC. The firm projects first-quarter sales to surge 684.2% year-over-year as installations expand across major South Korean hospitals. Additionally, Seers Technology anticipates exports of MobiCARE to the Middle East and seeks FDA clearance for the U.S. market.The Korea HeraldDaewoong vows to expand AI health monitoring for allDaewoong Pharmaceutical announced plans to expand its AI-based smart hospital bed monitoring system thynC to 100,000 hospital beds by the end of 2026, up from approximately 15,000 beds currently installed at 162 hospitals across Korea. The company, which partnered with Seers Technology as Korea's exclusive distributor and added three new functions from SkyLab, iKooB, and Puzzle AI, also set a target of reaching 300 billion won in annual revenue from its digital healthcare business. Daewoong's digital health sector reported 50.9 billion won in sales last year, representing a 123 percent increase, and aims to establish a 24-hour health monitoring system extending beyond hospitals to households.